| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| atenolol 5 mg/10 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| dikoboltedetat 300 mg/20 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| dikoboltedetat 300 mg/20 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| epoetin beta 4 000 enheter/0,3 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| epoetin beta 4 000 enheter/0,3 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| fentanyl (som fentanylcitrat) 500 mikrogram/10 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| fentanyl (som fentanylcitrat) 500 mikrogram/10 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| atosiban (som atosibanacetat) 37,5 mg/5 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| atosiban (som atosibanacetat) 37,5 mg/5 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| amoxicillin (som amoxicillintrihydrat) 80 milligram/milliliter och klavulansyra (som kaliumklavulanat) 11,4 milligram/milliliter, oral suspension |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| amoxicillin (som amoxicillintrihydrat) 80 milligram/milliliter och klavulansyra (som kaliumklavulanat) 11,4 milligram/milliliter, oral suspension |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
2 |
| digoxin 500 mikrogram/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| digoxin 500 mikrogram/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| atosiban (som atosibanacetat) 6,75 mg/0,9 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| atosiban (som atosibanacetat) 6,75 mg/0,9 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| enoxaparinnatrium 20 mg/0,2 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| enoxaparinnatrium 20 mg/0,2 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| dihydrokodeintartrat 50 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| dihydrokodeintartrat 50 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| prometazinhydroklorid 25 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| prometazinhydroklorid 25 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| lidokainhydroklorid 100 mg/5 ml injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| lidokainhydroklorid 100 mg/5 ml injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| fondaparinuxnatrium 7,5 mg/0,6 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| fondaparinuxnatrium 7,5 mg/0,6 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| tropisetron (som tropisetronhydroklorid) 2 mg/2 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| tropisetron (som tropisetronhydroklorid) 2 mg/2 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| hydromorfonhydroklorid 10 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| hydromorfonhydroklorid 10 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| tropisetron (som tropiseronhydroklorid) 5 mg/5 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| tropisetron (som tropiseronhydroklorid) 5 mg/5 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| noradrenalin (som noradrenalinbitartrat) 2 mg/2 ml, infusionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| noradrenalin (som noradrenalinbitartrat) 2 mg/2 ml, infusionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| hydromorfonhydroklorid 2 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| hydromorfonhydroklorid 2 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| propofol 200 mg/20 ml, injektionsvätska, emulsion, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| propofol 200 mg/20 ml, injektionsvätska, emulsion, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| lidokainhydroklorid 400 mg/20 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| lidokainhydroklorid 400 mg/20 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| laxkalcitonin 50 enheter/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| laxkalcitonin 50 enheter/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| metotrexat (som metotrexatnatrium) 5 mg/2 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| metotrexat (som metotrexatnatrium) 5 mg/2 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| noretindronenantat 200 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| noretindronenantat 200 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| natalizumab 300 mg/15 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| heparinnatrium 25 000 enheter/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| heparinnatrium 25 000 enheter/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| propofol 500 mg/50 ml, injektionsvätska, emulsion, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| propofol 500 mg/50 ml, injektionsvätska, emulsion, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| lidokainhydroklorid 400 mg/20 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| lidokainhydroklorid 400 mg/20 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| panitumumab 100 mg/5 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| panitumumab 100 mg/5 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| vinkristinsulfat 1 mg/ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| vinkristinsulfat 1 mg/ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| oktreotid (som oktreotidacetat) 100 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| oktreotid (som oktreotidacetat) 100 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| hydroxiprogesteronkaproat 250 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| hydroxiprogesteronkaproat 250 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| linezolid 600 mg/300 ml, infusionsvätska, lösning, påse |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| linezolid 600 mg/300 ml, infusionsvätska, lösning, påse |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| fondaparinuxnatrium 2,5 mg/0,5 ml, injektionsvätska, lösning, spruta |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| fondaparinuxnatrium 2,5 mg/0,5 ml, injektionsvätska, lösning, spruta |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| vinkristinsulfat 2 mg/2 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| vinkristinsulfat 2 mg/2 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| oktreotid (som oktreotidacetat) 1 mg/5 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| oktreotid (som oktreotidacetat) 1 mg/5 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| doxorubicinhydroklorid 20 mg/10 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| doxorubicinhydroklorid 20 mg/10 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| humant insulin (som humant lösligt insulin) 1 000 enheter/10 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| humant insulin (som humant lösligt insulin) 1 000 enheter/10 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| nalbufinhydroklorid 10 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| nalbufinhydroklorid 10 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| papaveretum 15,4 mg/ml + skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| papaveretum 15,4 mg/ml + skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
2 |
| papaveretum 15,4 mg/ml + skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
2 |
| papaveretum 15,4 mg/ml + skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| vinkristinsulfat 5 mg/5 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| vinkristinsulfat 5 mg/5 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| oktreotid (som oktreotidacetat) 500 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| oktreotid (som oktreotidacetat) 500 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| skopolaminhydrobromid 400 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| levobupivakain (som levobupivakainhydroklorid) 25 mg/10 ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| levobupivakain (som levobupivakainhydroklorid) 25 mg/10 ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| propofol 1 g/50 ml, injektionsvätska, emulsion, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| propofol 1 g/50 ml, injektionsvätska, emulsion, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| doxorubicinhydroklorid 50 mg/25 ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| doxorubicinhydroklorid 50 mg/25 ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| metotrexat (som metotrexatnatrium) 500 mg/20 ml, injektionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| metotrexat (som metotrexatnatrium) 500 mg/20 ml, injektionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| vinorelbin (som vinorelbintartrat) 10 mg/ml, infusionsvätska, lösning, flaska |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| vinorelbin (som vinorelbintartrat) 10 mg/ml, infusionsvätska, lösning, flaska |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| oktreotid (som oktreotidacetat) 50 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| oktreotid (som oktreotidacetat) 50 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| skopolaminhydrobromid 600 mikrogram/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| skopolaminhydrobromid 600 mikrogram/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |
| propranololhydroklorid 1 mg/ml, injektionsvätska, lösning, ampull |
Has presentation strength denominator unit (attribute) |
False |
mL |
Inferred relationship |
Some |
1 |
| propranololhydroklorid 1 mg/ml, injektionsvätska, lösning, ampull |
Has concentration strength denominator unit |
False |
mL |
Inferred relationship |
Some |
1 |